Antibody to ERBB2 promoter binding factor


Ontology type: sgo:Patent     


Patent Info

DATE

1997-08-05T00:00

AUTHORS

RAZIUDDIN , Fazlul Hoque Sarkar

ABSTRACT

The present invention provides a purified and isolated DNA-binding protein, HPBF, which specifically binds to the promoter region of the Her-2/neu (ERBB2/c-erbB-2) gene sequence, the presence of which provides an early indication of transition to a cancerous state has been found. The present invention also provides bioassays for screening substances for the ability to inhibit HPBF activity, the ability to inhibit the mitogenic activity of HPBF and the ability to inhibit HPBF production. The present invention further provides methods of inhibiting the biological activity mediated by HPBF comprising preventing the HPBF from binding to the promoter region of the ERBB2 gene sequence. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2620", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "RAZIUDDIN", 
        "type": "Person"
      }, 
      {
        "name": "Fazlul Hoque Sarkar", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1128/mcb.11.4.1875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004178925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/nar/12.23.8779", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004223950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1988.239", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019424593", 
          "https://doi.org/10.1038/bjc.1988.239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1988.239", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019424593", 
          "https://doi.org/10.1038/bjc.1988.239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.83.2.261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030989042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(85)90113-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045091546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.84.23.8498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048122735"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1997-08-05T00:00", 
    "description": "

The present invention provides a purified and isolated DNA-binding protein, HPBF, which specifically binds to the promoter region of the Her-2/neu (ERBB2/c-erbB-2) gene sequence, the presence of which provides an early indication of transition to a cancerous state has been found. The present invention also provides bioassays for screening substances for the ability to inhibit HPBF activity, the ability to inhibit the mitogenic activity of HPBF and the ability to inhibit HPBF production. The present invention further provides methods of inhibiting the biological activity mediated by HPBF comprising preventing the HPBF from binding to the promoter region of the ERBB2 gene sequence.

", "id": "sg:patent.US-5654406-A", "keywords": [ "antibody", "promoter binding", "invention", "DNA-Binding Protein", "Genetic Promoter Region", "HER-2/neu", "ErbBs", "gene sequence", "early indication", "transition", "cancerous state", "Biological Assay", "substance", "mitogenic activity", "method", "biological activity", "preventing", "binding" ], "name": "Antibody to ERBB2 promoter binding factor", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.420176.6", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.27235.31", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-5654406-A" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:26", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_03034.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-5654406-A'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-5654406-A'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-5654406-A'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-5654406-A'


 

This table displays all metadata directly associated to this object as RDF triples.

65 TRIPLES      15 PREDICATES      39 URIs      26 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-5654406-A schema:about anzsrc-for:2620
2 schema:author N32428ebfa6fc436e85615bbf837026f1
3 schema:citation sg:pub.10.1038/bjc.1988.239
4 https://doi.org/10.1016/0092-8674(85)90113-8
5 https://doi.org/10.1073/pnas.83.2.261
6 https://doi.org/10.1073/pnas.84.23.8498
7 https://doi.org/10.1093/nar/12.23.8779
8 https://doi.org/10.1128/mcb.11.4.1875
9 schema:datePublished 1997-08-05T00:00
10 schema:description <p>The present invention provides a purified and isolated DNA-binding protein, HPBF, which specifically binds to the promoter region of the Her-2/neu (ERBB2/c-erbB-2) gene sequence, the presence of which provides an early indication of transition to a cancerous state has been found. The present invention also provides bioassays for screening substances for the ability to inhibit HPBF activity, the ability to inhibit the mitogenic activity of HPBF and the ability to inhibit HPBF production. The present invention further provides methods of inhibiting the biological activity mediated by HPBF comprising preventing the HPBF from binding to the promoter region of the ERBB2 gene sequence.</p>
11 schema:keywords Biological Assay
12 DNA-Binding Protein
13 ErbBs
14 Genetic Promoter Region
15 HER-2/neu
16 antibody
17 binding
18 biological activity
19 cancerous state
20 early indication
21 gene sequence
22 invention
23 method
24 mitogenic activity
25 preventing
26 promoter binding
27 substance
28 transition
29 schema:name Antibody to ERBB2 promoter binding factor
30 schema:recipient https://www.grid.ac/institutes/grid.27235.31
31 https://www.grid.ac/institutes/grid.420176.6
32 schema:sameAs https://app.dimensions.ai/details/patent/US-5654406-A
33 schema:sdDatePublished 2019-04-18T10:26
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher N74982ad938de42e398a3440eac1089cd
36 sgo:license sg:explorer/license/
37 sgo:sdDataset patents
38 rdf:type sgo:Patent
39 N26237d68efdb4138ac0eafab2495a02c rdf:first N62ac3f04a0914376aee48b3e10329ade
40 rdf:rest rdf:nil
41 N32428ebfa6fc436e85615bbf837026f1 rdf:first Ned5cfbc5eee4442b823bcf151fc850c4
42 rdf:rest N26237d68efdb4138ac0eafab2495a02c
43 N62ac3f04a0914376aee48b3e10329ade schema:name Fazlul Hoque Sarkar
44 rdf:type schema:Person
45 N74982ad938de42e398a3440eac1089cd schema:name Springer Nature - SN SciGraph project
46 rdf:type schema:Organization
47 Ned5cfbc5eee4442b823bcf151fc850c4 schema:name RAZIUDDIN
48 rdf:type schema:Person
49 anzsrc-for:2620 schema:inDefinedTermSet anzsrc-for:
50 rdf:type schema:DefinedTerm
51 sg:pub.10.1038/bjc.1988.239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019424593
52 https://doi.org/10.1038/bjc.1988.239
53 rdf:type schema:CreativeWork
54 https://doi.org/10.1016/0092-8674(85)90113-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045091546
55 rdf:type schema:CreativeWork
56 https://doi.org/10.1073/pnas.83.2.261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030989042
57 rdf:type schema:CreativeWork
58 https://doi.org/10.1073/pnas.84.23.8498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048122735
59 rdf:type schema:CreativeWork
60 https://doi.org/10.1093/nar/12.23.8779 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004223950
61 rdf:type schema:CreativeWork
62 https://doi.org/10.1128/mcb.11.4.1875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004178925
63 rdf:type schema:CreativeWork
64 https://www.grid.ac/institutes/grid.27235.31 schema:Organization
65 https://www.grid.ac/institutes/grid.420176.6 schema:Organization
 




Preview window. Press ESC to close (or click here)


...